Orexigen Therapeutics beats by $0.07, misses on revenue

• Orexigen Therapeutics (NASDAQ:OREX): Q3 EPS of -$0.09 beats by $0.07.
• Revenue of $10M (-67.6% Y/Y) misses by $2.17M.
• Press Release